Application of Rhus chinensis fruit extract in preparing drugs for preventing and treating hyperuricemia
Patent Information
- Application Number
- CN202210118823.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-02-08
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2042-02-08
AI Technical Summary
但是,目前临床上主要使用的两种黄嘌呤氧化酶抑制剂(非布司他和别嘌醇),均存在着较为严重的副作用,如皮疹、胃肠道反应、肝肾损伤和血小板减少等,需要长期服用且价格较贵
[0015] Compared with the prior art, the present invention has the following beneficial effects: the present invention explores the use of Saliarum fruit extract as a xanthine oxidase inhibitor and opens up a new research field of Saliarum fruit. The present invention detects the inhibitory activity of the Xanthopus chinensis fruit extract on xanthine oxidase through in vivo and in vitro tests; both in vivo and in vitro test results show that the Xanthopus chinensis fruit extract or its purified components can very effectively inhibit xanthine oxidation. enzyme activity, and can inhibit the production of uric acid by inhibiting the activity of xanthine oxidase in the liver and blood of mice, thus effectively preventing and treating high uric acid. The fruit of the present invention is an edible plant seasoning, and is a conventional grain and oil economic crop. It is highly safe, widely distributed in my country, and the raw materials are easy to obtain. Based on the above reasons, the fruit extract of the fruit of the fruit extract or its purified component It has very good development and utilization prospects as a xanthine oxidase inhibitor.
Smart Images

Figure CN116602999B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medical technology, and in particular relates to the application of a Rhus chinensis fruit extract in the preparation of a xanthine oxidase inhibitor, a drug for preventing and treating hyperuricemia, and a functional food. Background Art
[0002] Xanthine oxidase (XOD) is a complex flavoprotein protease that is mainly found in the liver. It is an extremely important enzyme in the process of metabolizing purine to produce uric acid (UA) in the human body. Xanthine oxidase can catalyze xanthine and hypoxanthine in the body to produce uric acid and peroxide free radicals, so inhibiting its activity can prevent or reduce the production of uric acid in the body. Therefore, xanthine oxidase inhibitors have been widely regarded as an effective uric acid-lowering drug in recent years. However, the two main xanthine oxidase inhibitors currently used in clinical practice (febuxostat and allopurinol) both have relatively serious side effects, such as rash, gastrointestinal reactions, liver and kidney damage, and thrombocytopenia, and need to be taken for a long time and are expensive. Therefore, if some low-cost and side-effect-free natural products can be developed from natural edible plant raw materials as xanthine oxidase inhibitors, it can well solve the problem of large side effects and high cost of existing xanthine oxidase inhibitors.
[0003] Rhus chinensis Mill. is a species of the genus Rhus in the Anacardiaceae family. Its fruit is often used as a natural source of beverages, spices and edible fruit oils. It is a valuable economic tree and is widely distributed. Currently, there is no report that Rhus chinensis Mill. fruit or its extract can inhibit the activity of xanthine oxidase. Summary of the invention
[0004] In view of this, the object of the present invention is to provide the use of Rhus chinensis fruit extract in the preparation of xanthine oxidase inhibitors, drugs for preventing and treating hyperuricemia, and functional foods. The present invention finds that the Rhus chinensis fruit extract can not only effectively inhibit the activity of xanthine oxidase in vitro, but also effectively inhibit the activity of xanthine oxidase in the liver and plasma of hyperuricemia mice in vivo, thereby inhibiting the generation of uric acid, through in vitro xanthine oxidase inhibition tests and in vivo tests in mice. The present invention provides a new use for Rhus chinensis fruit.
[0005] The invention provides application of a Rhus chinensis fruit extract in preparing a xanthine oxidase inhibitor.
[0006] Preferably, the Rhus chinensis fruit extract is an ethanol extract of Rhus chinensis fruit.
[0007] Preferably, the method for preparing the Rhus chinensis fruit extract comprises the following steps: mixing the Rhus chinensis fruit with an ethanol aqueous solution, performing ultrasonic extraction, collecting the filtrate, concentrating it, and freeze-drying it.
[0008] Preferably, the mass concentration of the ethanol aqueous solution is 75% to 85%.
[0009] Preferably, the mass volume ratio of the Rhus chinensis fruit to the ethanol aqueous solution is 1 g: (3-8) ml.
[0010] Preferably, the temperature of the ultrasonic extraction is 23-27° C., the number of ultrasonic extractions is 1-3 times, the time of each ultrasonic extraction is 25-35 minutes, and the power of the ultrasonic extraction is 150-250W.
[0011] Preferably, the dosage form of the xanthine oxidase inhibitor is a liquid preparation, and the concentration of the Rhus chinensis fruit extract in the xanthine oxidase inhibitor is 40-300 μg / ml.
[0012] The present invention also provides the use of the Rhus chinensis fruit extract in preparing a medicine for preventing and / or treating hyperuricemia.
[0013] Preferably, the drug is an oral preparation.
[0014] The present invention also provides the use of the Rhus chinensis fruit extract in preparing functional food for preventing and / or treating hyperuricemia.
[0015] Compared with the prior art, the present invention has the following beneficial effects: the present invention explores the use of Rhus chinensis fruit extract as a xanthine oxidase inhibitor, and opens up a new research field for Rhus chinensis fruit. The present invention detects the inhibitory activity of Rhus chinensis fruit extract on xanthine oxidase through in vivo and in vitro tests; the results of in vivo and in vitro tests both show that the Rhus chinensis fruit extract or its purified components can very effectively inhibit the activity of xanthine oxidase, and can inhibit uric acid production by inhibiting the activity of xanthine oxidase in mouse liver and blood, thereby effectively preventing and treating hyperuricemia. The Rhus chinensis fruit described in the present invention is an edible plant seasoning, and at the same time belongs to a conventional grain and oil economic crop, has high safety, is widely distributed in my country, and raw materials are easily available; for the above reasons, the Rhus chinensis fruit extract or its purified components have very good development and utilization prospects as a xanthine oxidase inhibitor. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 The inhibitory effects of the extract (A) and the purified fraction (B) of the extract (A) in 80% ethanol aqueous solution of Rhus chinensis fruit on xanthine oxidase in vitro; all values are expressed as mean ± SD (n = 3); different letters in the same bar graph indicate significant differences (p < 0.05);
[0017] Figure 2The effect of 80% ethanol aqueous solution extract of Rhus chinensis fruit on xanthine oxidase (XOD) activity in plasma and liver tissue of hyperuricemia model mice; all values are expressed as mean ± SE (n = 10); different letters in the same bar graph indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw extract) and YH is the high-dose group (800 mg / kg b.w extract);
[0018] Figure 3 The effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on uric acid (UA) levels in plasma and urine of hyperuricemia mice; all values are expressed as mean ± SE (n = 10); different letters in the same bar graph indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw extract) and YH is the high-dose group (800 mg / kg bw extract).
[0019] Figure 4 The effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in the liver of hyperuricemia mice; all values are expressed as mean ± SE (n = 10); different letters in the same bar graph indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw extract) and YH is the high-dose group (800 mg / kg bw extract). DETAILED DESCRIPTION
[0020] The invention provides application of a Rhus chinensis fruit extract in preparing a xanthine oxidase inhibitor.
[0021] In the present invention, the Rhus chinensis fruit extract is obtained by extracting Rhus chinensis fruit as a raw material; in the present invention, the Rhus chinensis fruit extract is preferably an ethanol extract of Rhus chinensis fruit, and more preferably an extract of 75% to 85% ethanol aqueous solution. In the present invention, the dosage form of the xanthine oxidase inhibitor is preferably a liquid preparation, and the concentration of the Rhus chinensis fruit extract in the xanthine oxidase inhibitor is preferably 40 to 300 μg / ml, and more preferably 80 to 200 μg / ml. In the present invention, the solvent of the liquid preparation is preferably an ethanol aqueous solution.
[0022] In the present invention, the method for preparing the Rhus chinensis fruit extract preferably comprises the following steps: mixing the Rhus chinensis fruit with an ethanol aqueous solution, ultrasonically extracting, collecting the filtrate, concentrating, and freeze-drying.
[0023] In the present invention, first, the Rhus chinensis fruit is mixed with an ethanol aqueous solution and ultrasonically extracted. In the present invention, the mass concentration of the ethanol aqueous solution is preferably 75% to 85%, more preferably 78 to 82%, and more preferably 80%. The present invention has no special restrictions on the source of the Rhus chinensis fruit, and the Rhus chinensis fruit dried from conventional sources in the art can be used. Before the Rhus chinensis fruit is mixed with the ethanol aqueous solution, the dried Rhus chinensis fruit is crushed and sieved to collect the undersize components. The present invention has no special restrictions on the crushing method, and the conventional crushing method in the art can be used. The mesh size of the sieved sieve is preferably 40-60 meshes. In the present invention, the mass volume ratio of the Rhus chinensis fruit to the ethanol aqueous solution is preferably 1g: (3 to 8) ml, more preferably 1g: (4 to 6) ml, and more preferably 1g: 5ml. In the present invention, the temperature of the ultrasonic extraction is preferably 23-27°C, more preferably 24-26°C, and more preferably 25°C; the number of ultrasonic extractions is preferably 1-3 times, and more preferably 2 times; the time of each ultrasonic extraction is preferably 25-35 minutes, and more preferably 28-32 minutes, and more preferably 30 minutes; the power of the ultrasonic extraction is preferably 150-250W, and more preferably 200W. In the present invention, the second or third extraction is an extraction performed by mixing the filter residue after the first extraction as a raw material with an ethanol aqueous solution.
[0024] The present invention collects the filtrate after the ultrasonic extraction is completed; the method of collecting the filtrate is preferably filtration; in the present invention, the filtration is preferably performed by negative pressure filtration using a Buchner funnel filter paper; in the present invention, when the number of extractions is greater than 1, the collected filtrate preferably also includes merging the filtrates of multiple extractions after filtration.
[0025] After collecting the filtrate, the filtrate is concentrated and freeze-dried to obtain the Rhus chinensis fruit extract. In the present invention, the concentration method is preferably evaporation and concentration at 45°C on a rotary evaporator, and the concentration multiple is preferably 5 times; the freeze-drying temperature is preferably -60 to -50°C, more preferably -56°C, and the freeze-drying time is preferably 45 to 50 hours, more preferably 48 hours.
[0026] After obtaining the Rhus chinensis fruit extract, the present invention preferably further comprises the step of purifying the Rhus chinensis fruit extract to obtain a purified component of the Rhus chinensis fruit extract. In the present invention, the purification comprises redissolving the Rhus chinensis fruit extract with water to obtain an aqueous solution of the Rhus chinensis fruit extract, then mixing the aqueous solution of the Rhus chinensis fruit extract with ethyl acetate for extraction, separating and purifying the extracted ethyl acetate phase with a gel chromatography column to obtain a plurality of purified samples of different polarities; finally, the obtained purified samples of different polarities are measured by an in vitro xanthine oxidase inhibition test, and the sample with the strongest in vitro xanthine oxidase inhibition activity is the purified component of the Rhus chinensis fruit extract. The present invention does not specifically limit the specific operation of the in vitro xanthine oxidase inhibition test, and the conventional in vitro xanthine oxidase inhibition test in the art can be used.
[0027] The present invention also provides the use of the Rhus chinensis fruit extract in the preparation of a medicament for preventing and / or treating hyperuricemia. In the present invention, the medicament is preferably an oral preparation. In the present invention, the medicament preferably comprises the Rhus chinensis fruit extract and a pharmaceutically acceptable adjuvant thereof, and the present invention has no particular limitation on the type and amount of the adjuvant. In the present invention, the preparation method of the Rhus chinensis fruit extract is described in the above-mentioned records, which will not be repeated here.
[0028] The present invention also provides the use of the Rhus chinensis fruit extract in the preparation of a functional food for preventing and / or treating hyperuricemia. In the present invention, the functional food uses the Rhus chinensis fruit extract as an effective ingredient, and the present invention has no special restrictions on the preparation method of the functional food, and the conventional functional food preparation method in the art can be used.
[0029] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0030] Example 1
[0031] In vitro inhibition of xanthine oxidase by 80% ethanol aqueous solution extract of Rhus chinensis fruit and its purified fractions
[0032] Sample preparation
[0033] Preparation of 80% ethanol aqueous solution extract of Rhus chinensis fruit
[0034] The specific method is as follows: 1L of 80% ethanol aqueous solution is mixed with 200g of crushed and sieved Rhus chinensis fruit for ultrasonic extraction; the extraction temperature is 25℃, the extraction time is 30min, and the ultrasonic power is 200W. After the first extraction, the supernatant and bottom sediment are collected by centrifugation at room temperature 4000r for 15min, and the supernatant is filtered by negative pressure using Buchner funnel filter paper to collect the filtrate and residue. The sediment and residue are mixed with 1L of 80% ethanol aqueous solution and extracted again. The temperature, time and power of the repeated extraction are kept the same as those of the first extraction; after filtration, the filtrates of the two extractions are combined, and then frozen at -30℃ and freeze-dried for 48h using a freeze dryer at a temperature of -52℃ and a vacuum degree of <0.1Mpa.
[0035] Preparation of purified fractions from 80% ethanol aqueous solution extract of Rhus chinensis fruit
[0036] 100g of 80% ethanol aqueous solution extract of Rhus chinensis fruit was re-dissolved in 2L water to form a suspension, divided into three parts, and then extracted with petroleum ether, ethyl acetate and n-butanol respectively. After extraction, petroleum ether phase / water phase, ethyl acetate phase / water phase, and n-butanol phase / water phase were obtained respectively. The samples of each phase were measured by in vitro xanthine oxidase inhibition test, and the ethyl acetate phase sample had the strongest xanthine oxidase inhibition activity. Then a chromatography column with an outer diameter of 80mm and a length of 1000mm was used, 100-200 mesh silica gel powder was used as filler, and dichloromethane and methanol solutions of different proportions were used as eluents. The ethyl acetate phase was separated and purified according to different polarities, and a total of 26 samples were obtained. The 26 samples were then measured by in vitro xanthine oxidase inhibition test, and the sample with the strongest inhibitory activity was the purified component of the 80% ethanol aqueous solution extract of Rhus chinensis fruit.
[0037] Xanthine oxidase inhibitory activity assay
[0038] The 80% ethanol aqueous solution extract of Rhus chinensis fruit and 26 separated components were used as samples. First, 1U / ml xanthine oxidase solution was prepared with PBS solution at pH 7.5 and concentration of 0.2M, and then 0.5mg / ml xanthine solution was prepared with PBS solution at pH 7.5 and concentration of 0.2M as substrate reaction solution. The 10mg / ml sample mother solution was diluted to the required concentration using PBS solution at pH 7.5 and concentration of 0.2M. The reaction system of the control group was 100μl PBS solution + 100μl xanthine oxidase solution + 100μl 80% ethanol aqueous solution + 100μl xanthine solution + 100μl 1M hydrochloric acid solution. The reaction system of the sample treatment group was 100μl PBS solution + 100μl xanthine oxidase solution + 100μl sample + 100μl xanthine solution + 100μl 1M hydrochloric acid solution. Both groups were set up with blank controls. The whole reaction system was incubated at 37°C for 30 min, and the absorbance was measured at 290 nm. Allopurinol, a commonly used xanthine oxidase inhibitor in clinical practice, was used as a positive control.
[0039] Test results
[0040] The results of the inhibition of xanthine oxidase by 80% ethanol aqueous solution extract of Rhus chinensis fruit and its purified fraction with the strongest inhibitory activity are shown in the figure. Figure 1 80% ethanol aqueous solution extract of Rhus chinensis fruit ( Figure 1 A) and the most active purified fraction ( Figure 1 The inhibitory effect of B) on xanthine oxidase showed a dose effect, and its inhibitory effect increased with the increase of concentration. When the extract concentration was 200 μg / mL, its inhibition rate exceeded 60%, and its IC 50 The value was 131.2 + 3.43 μg / mL, while the IC 50 The value was 6.32±1.25μg / mL, and the inhibitory effect was higher than IC 50 The positive drug allopurinol with a value of 9.45±0.96μg / mL is stronger. It can be seen that the 80% ethanol extract of Rhus chinensis fruit has a very significant inhibitory effect on xanthine oxidase, and its most active purified component even has a stronger inhibitory activity than allopurinol.
[0041] Table 1 Inhibitory effects of allopurinol, 80% ethanol aqueous solution extract of Rhus chinensis fruit and purified fractions of the extract on xanthine oxidase in vitro
[0042]
[0043] Note: All values are expressed as mean ± SD (n = 3); different letters indicate significant differences (p < 0.05);
[0044] Example 2
[0045] The 80% ethanol aqueous solution extract of Rhus chinensis fruit inhibits xanthine oxidase activity in plasma and liver of hyperuricemia mice
[0046] A mouse hyperuricemia model was established by combining high-purine yeast feed with intraperitoneal injection of potassium oxonate. The inhibitory effect of 80% ethanol aqueous solution extract of Rhus chinensis fruit on xanthine oxidase in plasma and liver of hyperuricemia mice induced by high-purine diet plus potassium oxonate was observed through animal model experiments. The uric acid (UA) content in blood and urine was also measured.
[0047] Test materials
[0048] animal
[0049] Kunming male mice (20 g-22 g) were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd.
[0050] Preparation of 80% ethanol aqueous solution extract of Rhus chinensis fruit
[0051] 1L of 80% ethanol aqueous solution was mixed with 200g of Rhus chinensis fruit for ultrasonic extraction; the extraction temperature was 25°C, the extraction time was 30min, and the ultrasonic power was 200W. After the first extraction, the filtrate and the residue were collected by filtration, and the residue was mixed with 1L of 80% ethanol aqueous solution for re-extraction, and the temperature, time and power of the re-extraction were kept consistent with those of the first extraction; after filtration, the filtrates of the two extractions were combined, and then frozen at -30°C and freeze-dried in a freeze dryer at a temperature of -52°C and a vacuum degree of <0.1Mpa for 48h to obtain the product.
[0052] Modeling and testing
[0053] All Kunming male mice were SPF mice weighing 20-22 g. Before the experiment, 50 mice were randomly divided into 5 groups, 10 mice in each group, namely: control group (C group), model group (M group), positive control group (P group), Rhus chinensis extract low-dose group (YL group) and Rhus chinensis extract high-dose group (YH group).
[0054] After the experiment started, the C and M groups were gavaged with normal saline every day, the P group was gavaged with allopurinol solution every day, the gavage dose was 5 mg / kg bw, the YL group was gavaged with 80% ethanol aqueous solution extract of Rhus chinensis fruit every day, the gavage dose was 400 mg / kg bw, and the YH group was gavaged with 80% ethanol aqueous solution extract of Rhus chinensis fruit every day, the gavage dose was 800 mg / kg bw. Except for the C group, which consumed ordinary feed, all the other four groups of experimental mice consumed high-purine feed containing yeast, and were gavaged with the corresponding 80% ethanol aqueous solution extract of Rhus chinensis fruit and allopurinol every day. After 6 months, the other four groups except the C group were intraperitoneally injected with potassium oxonate every day for 7 consecutive days. After 7 days, all mice were fasted but not water, and all mice were anesthetized and euthanized by cervical dislocation after collecting 24h urine. Blood was collected and centrifuged to collect plasma for subsequent index measurement. The liver tissue of the mice was then removed, rinsed with normal saline, frozen in liquid nitrogen and stored at -80℃ for later use.
[0055] Test results
[0056] (1) Inhibition of XOD activity in plasma and liver tissue of mice with hyperuricemia by 80% ethanol aqueous solution extract of Rhus chinensis fruit
[0057] Xanthine oxidase is a key enzyme system in the body that metabolizes purine nucleotides into uric acid. It is particularly abundant in the liver, so the liver is also the main place where uric acid is produced. Therefore, inhibiting the activity of xanthine oxidase in liver tissue is also one of the effective means to prevent hyperuricemia, and the activity of xanthine oxidase in plasma can also effectively reflect the overall situation of the body. The results of this experiment are as follows Figure 2 As shown, compared with group C, the XOD activity in liver tissue and plasma of mice induced by high purine diet and potassium oxonate was significantly higher than that of other groups (p < 0.05), but the XOD activity in liver tissue and plasma was significantly decreased after pretreatment with allopurinol (group P) and samples (YL and YH) (p < 0.05), and there was no significant difference in XOD activity in plasma between group P and group YH (p > 0.05). More importantly, the XOD level in liver tissue of group YH was significantly lower than that of group P (p < 0.05), and there was no significant difference with group C (p > 0.05). The results show that the 80% ethanol aqueous solution extract of Rhus chinensis can effectively inhibit the activity of xanthine oxidase in liver tissue and plasma in vivo.
[0058] Table 2 Effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on xanthine oxidase (XOD) activity in plasma and liver tissue of hyperuricemia model mice
[0059]
[0060] Note: All values are expressed as mean ± SE (n = 10); different letters indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg b.w allopurinol); YL is the low-dose group (400 mg / kg b.w extract) and YH is the high-dose group (800 mg / kg b.w extract).
[0061] Effects of 80% ethanol aqueous solution extract of Rhus chinensis fruit on UA levels in plasma and urine of hyperuricemia mice
[0062] Figure 3 The results showed that the UA levels in plasma and urine of mice induced by high-purine diet and potassium oxonate were significantly increased in M group compared with the normal group (C group) (p < 0.05), and the UA levels in plasma and urine of allopurinol (P group) and sample (YL and YH) groups were significantly decreased after pretreatment (p < 0.05). The amount of UA in plasma of YL group was not significantly different from that of P group (p > 0.05). More importantly, the UA in plasma of YH group was significantly lower than that of P group and YL group (p < 0.05), and there was no significant difference with the normal group (C group) (p > 0.05), indicating that the blood uric acid in YH group returned to normal levels. There was no significant difference in the UA levels in urine of P group, YL group and YH group, and there was no significant difference with C group (p > 0.05). These results further indicate that the 80% ethanol aqueous solution extract of Rhus chinensis can effectively inhibit the production of uric acid by inhibiting the activity of xanthine oxidase in the body, thereby preventing the occurrence of hyperuricemia.
[0063] Table 3 UA levels in plasma and urine of mice induced by high-purine diet plus potassium oxonate
[0064]
[0065] Note: All values are expressed as mean ± SE (n = 10); different letters indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg b.w allopurinol); YL is the low-dose group (400 mg / kg b.w extract) and YH is the high-dose group (800 mg / kg b.w extract).
[0066] Figure 4 The results are the results of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels in the liver tissue of mice induced by a high-purine diet and potassium oxonate. The results show that there is no significant difference in the AST and ALT levels in the liver of each group compared with group C (p>0.05). This indicates that the liver of mice with high uric acid is not damaged and the extract of the fruit of the salt bran tree does not cause liver damage in mice.
[0067] Table 4 Levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in liver tissue of mice induced by high-purine diet plus potassium oxonate
[0068]
[0069] Note: All values are expressed as mean ± SE (n = 10); different letters indicate significant differences (p < 0.05); C is the control group; M is the model group; P is the positive group (5 mg / kg bw allopurinol); YL is the low-dose group (400 mg / kg bw extract) and YH is the high-dose group (800 mg / kg bw extract).
[0070] As can be seen from the above examples, the Rhus chinensis fruit extract or its purified components can be used as xanthine oxidase inhibitors to effectively inhibit the activity of xanthine oxidase and thus inhibit uric acid production without damaging the liver. Therefore, the Rhus chinensis fruit extract can be used to develop xanthine oxidase inhibitors.
[0071] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. Use of Rhus chinensis fruit extract in the preparation of a medicament for preventing and / or treating hyperuricemia, characterized in that: The preparation method of the Rhus chinensis fruit extract comprises the following steps: mixing the Rhus chinensis fruit with an ethanol aqueous solution, ultrasonically extracting, collecting the filtrate, concentrating, and freeze-drying; The volume concentration of the ethanol aqueous solution is 75% to 85%; The mass volume ratio of the Rhus chinensis fruit to the ethanol aqueous solution is 1 g: (3-8) ml; The temperature of the ultrasonic extraction is 23-27° C., the number of ultrasonic extractions is 1-3 times, the time of each ultrasonic extraction is 25-35 minutes, and the power of the ultrasonic extraction is 150-250W.
2. The use according to claim 1, characterized in that: The medicine is an oral preparation.
